Business

AstraZeneca Pharma India Q3 results: Net profit declines 21% to Rs 21 cr

NEW DELHI: Drug firm on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December.

The company had posted a net profit of Rs 26.70 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.

Revenue from operations of the company stood at Rs 200.25 crore for the quarter under consideration. It was Rs 223.86 crore for the same period a year ago, it added.

Shares of AstraZeneca Pharma India closed at Rs 3,899.40 per scrip on BSE, up 0.11 percent from its previous close.




Source link

Show More

Related Articles

Back to top button